1 |
M |
RINWITGGIA |
72 |
81 |
10 |
90% (SARS-CoV) |
2 |
M |
VYRINWITGG |
70 |
79 |
10 |
90% (SARS-CoV) |
3 |
NSP3 |
DCEEEEFEPS |
935 |
944 |
10 |
50% (SARS-CoV), 505 (MERS-CoV), 50% (OC43) |
4 |
NSP2 |
EHEHEIAWYT |
233 |
242 |
10 |
80% (SARS-CoV) |
5 |
NSP3 |
GDCEEEEFEP |
934 |
943 |
10 |
50% (SARS-CoV), 50% (MERS-CoV) |
6 |
2'-O-ribose methyltransferase (NSP16) |
GHFAWWTAF |
6983 |
6991 |
9 |
88.89% (SARS-CoV) |
7 |
2'-O-ribose methyltransferase (NSP16) |
GHFAWWTAFV |
6983 |
6992 |
10 |
90% (SARS-CoV) |
8 |
2'-O-ribose methyltransferase (NSP16) |
HFAWWTAFV |
6984 |
6992 |
9 |
88.89% (SARS-CoV) |
9 |
NSP2 |
KLNEEIAIIL |
468 |
477 |
10 |
80% (SARS-CoV) |
10 |
NSP2 |
LNEEIAIILA |
469 |
478 |
10 |
90% (SARS-CoV) |
11 |
NSP4 |
LVPFWITIA |
3135 |
3143 |
9 |
66.67% (SARS-CoV) |
12 |
NSP4 |
LVPFWITIAY |
3135 |
3144 |
10 |
70% (SARS-CoV) |
13 |
2'-O-ribose methyltransferase (NSP16) |
MGHFAWWTA |
6982 |
6990 |
9 |
88.89% (SARS-CoV) |
14 |
2'-O-ribose methyltransferase (NSP16) |
MGHFAWWTAF |
6982 |
6991 |
10 |
90% (SARS-CoV), 90% (MERS-CoV) |
15 |
NSP4 |
PLVPFWITIA |
3134 |
3143 |
10 |
70% (SARS-CoV) |
16 |
NSP4 |
TKHFYWFFS |
3150 |
3158 |
9 |
55.56% (SARS-CoV) |
17 |
NSP4 |
VPFWITIAY |
3136 |
3144 |
9 |
77.78% (SARS-COV) |
18 |
NSP4 |
VPFWITIAYI |
3136 |
3145 |
10 |
70% (SARS-CoV) |
19 |
S |
NVTWFHAIHV |
61 |
70 |
10 |
60% (SARS-CoV) |
20 |
ORF7b |
IMLIIFWFSL |
23 |
32 |
10 |
100% (SARS-CoV) |
21 |
ORF7b |
MLIIFWFSL |
24 |
32 |
9 |
100% (SARS-CoV) |